Showing results (31-40 of 409) with videos related to
Sort By:
Pageof 41
Journal of Diabetes Investigation|November 21, 2014
Epidemic trend of diabetes in China: For the Xiaoren Pan Distinguished Research Award in AASDXiaoping Chen, Wenying YangAntioxidants (Basel, Switzerland)|June 24, 2022
Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of ActionMeiming Su, Wenqi Zhao, Suowen Xu, et al.Diabetes Care|October 23, 2013
Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes surveyXianghai Zhou, Qing Qiao, Linong Ji, et al.American Journal of Physiology. Endocrinology and Metabolism|November 2, 2017
Curcumin and other dietary polyphenols: potential mechanisms of metabolic actions and therapy for diabetes and obesityTianru Jin, Zhuolun Song, Jianping Weng, et al.Plos One|November 13, 2015
Seasonal Dynamics of Soil Labile Organic Carbon and Enzyme Activities in Relation to Vegetation Types in Hangzhou Bay Tidal Flat WetlandXuexin Shao, Wenying Yang, Ming WuDiabetes/Metabolism Research and Reviews|September 27, 2016
Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational studyBo Zhang, Jing Zhao, Wenying Yang, et al.Journal of Diabetes|April 25, 2020
Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT)Leili Gao, Puhong Zhang, Jianping Weng, et al.Communications Medicine|February 22, 2023
Higher mitochondrial DNA copy number is associated with metformin-induced weight lossJing Wang, Hua Liang, Rong Huang, et al.Diabetes, Obesity & Metabolism|January 21, 2017
Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in ChinaLinong Ji, Puhong Zhang, Dongshan Zhu, et al.Diabetes Technology & Therapeutics|July 15, 2015
Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China--Study Design and Baseline CharacteristicsLinong Ji, Puhong Zhang, Jianping Weng, et al.Pageof 41